Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

Safety and Efficacy of Pegvisomant in Children With Growth Hormone Excess

Conditions: Pituitary Disease
Interventions: Drug: Pegvisomant
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 19, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments